Late-onset Epstein-Barr virus (EBV)-negative extranodal B-precursor lymphoblastic lymphoma of donor origin after hematopoietic stem cell transplantation (HSCT) [3]

Bone Marrow Transplantation

Volumn 31, Issue 11, 2003, Pages 1071-1072

  Bredt, M ^a   Schonfeld G ^d   Kleeberger, W ^a   Konig E ^a   Kroning H ^b   Kettner, E ^b   Al Ali, H K ^c   Niederwieser, D ^c   Kreipe, H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Stadtisches Klinikum Magdeburg   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; CYTARABINE; DNA; DOXORUBICIN; HLA ANTIGEN; IDARUBICIN; METHOTREXATE; MITOXANTRONE; PREDNISONE; VINCRISTINE;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; B CELL LYMPHOMA; BONE MARROW BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CASE REPORT; CYTOGENETICS; DONOR; EPSTEIN BARR VIRUS; FEMALE; GRAFT VERSUS HOST REACTION; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HISTOPATHOLOGY; HLA MATCHING; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KARYOTYPE; LETTER; LEUKEMIA REMISSION; LYMPHOBLASTOMA; LYMPHOPROLIFERATIVE DISEASE; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SEPSIS; STEM CELL; TANDEM REPEAT; Y CHROMOSOME;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CYCLOPHOSPHAMIDE; DOXORUBICIN; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HERPESVIRUS 4, HUMAN; HUMANS; LEUKEMIA, B-CELL, ACUTE; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; NEOPLASMS, SECOND PRIMARY; PREDNISONE; TIME FACTORS; TRANSPLANTATION, ISOGENEIC; VINCRISTINE;

EID: 0038685986     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bmt.1704035     Document Type: Letter

References (9)

1. Deeg HJ, Socie G. Malignancies after hematopoietic stem cell transplantation: many questions, some answers. Blood 1998; 91: 1833-1844.
2. Zutter MM, Durnam DM, Hackman RC et al. Secondary T-cell lymphoproliferation after marrow transplantation. Am J Clin Pathol 1990; 94: 714-721.
3. Meignin V, Devergie A, Brice P et al. Hodgkin's disease of donor origin after allogeneic bone marrow transplantation for myelogeneous chronic leukemia. Transplantation 1998; 65: 595-597.
4. Lawler M, Locasciulli A, Longoni D et al. Leukaemic transformation of donor cells in a patient receiving a second allogeneic bone marrow transplant for severe aplastic anaemia. Bone Marrow Transplant 2002; 29: 453-456.
5. Curtis RE, Travis LB, Rowlings PA et al. Risk of lymphoproliferative disorders after bone marrow transplantation: a multi-institutional study. Blood 1999; 94: 2208-2216.
6. Gomyo H, Murayama T, Kizaki T et al. Epstein-Barr virus-negative high grade B cell lymphoma of donor origin developing 19 months after unrelated allogeneic bone marrow transplantation. Bone Marrow Transplant 2000; 26: 577-579.
7. Nelson BP, Nalesnik MA, Bahler DW et al. Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol 2000; 24: 375-385.
8. Wilkens L, Bredt M, Flemming A et al. Detection of chromosomal aberrations in well-differentiated hepatocellular carcinoma by bright-field in situ hybridization. Mod Pathol 2002; 15: 470-477.
9. Kleeberger W, Rothamel T, Glockner S et al. High frequency of epithelial chimerism in liver transplants demonstrated by microdissection and STR-analysis. Hepatology 2002; 35: 110-116.